Alpha-1 antitrypsin deficiency (AATD) has turned into the most crowded proving ground in genetic medicine, with five editing companies reporting fresh...

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

This week's clinical update includes FDA RMAT designation to Beam Therapeutics' BEAM-302 for the treatment of alpha-1 antitrypsin deficiency as well...